The vultures are too early.
The report of Resapp's death was an exaggeration.
- Forums
- ASX - By Stock
- RAP
- Ann: Pfizer raises scheme consideration to A$0.208 per share
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-68
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online